IGIB - (iShares Intermediate-Term Corporate Bond ETF)

 IGIBのチャート


 IGIBの企業情報

symbol -
会社名
分野(sector)   
産業(industry)   
業種   
概要     
本社所在地 --
代表者氏名
代表者役職名
電話番号 --
設立年月日 --
市場名 --
ipoyear ―年
従業員数 --
url --
nasdaq_url https://www.nasdaq.com/symbol/igib
adr_tso
EBITDA
終値(lastsale) 52.4697
時価総額(marketcap) 5758549575
時価総額
売上高
企業価値(EV)
当期純利益
決算概要

 IGIBのテクニカル分析


 IGIBのニュース

   Has Delhi's coronavirus curve plateaued?  2020/07/22 13:39:09 Economic Times India
At the core of Delhi's transition from a corona capital to a model city where the number of COVID-19 cases has been consistently falling is possibly its testing strategy, say experts as they try to decipher the trajectory of the disease. Though there are no precise answers to the many questions of whether the Delhi curve has plateaued, dipped decisively or reached its peak, a close examination of testing patterns could hold the key.While some scientists believe ramped up testing has helped in breaking the transmission chain, there are others who say the reduced numbers could be because of the focus on the rapid antigen test that can throw up false negatives. Testing helps in identifying and isolating the infected, thus breaking the transmission chain, said Anurag Agarwal, director of the Institute of Genomics and Integrative Biology (IGIB). Ever since the antigen tests came, many more have been tested than previously. It breaks the chain, then they go into isolation. The number of people that each infected person infects goes down if you find them early, Agarwal told PTI.In virologist Shahid Jameel's view, rapid antigen tests don't have the same accuracy as RT-PCR tests.
   CSIR submits 53 genome sequences of coronavirus to global body; to share 450 more by May 15  2020/05/07 07:36:20 Economic Times India
Amidst concerns that coronavirus have undergone mutation and the new strain maybe more contagious, India's premier R&D organisation, CSIR, has submitted as many as 53 genome sequences of the virus to a global genome database, a move that may help in better understanding of the virus and developing a vaccine. The Council for Scientific and Industrial Research (CSIR) is also planning to submit additional 450 genome sequence data of coronavirus by May 15, its Director General Shekhar Mande told PTI. CSIR's Institute of Genomics and Integrative Biology (IGIB), Delhi, Centre for Cellular and Molecular Biology (CCMB), Hyderabad and Institute of Microbial Technology, Chandigarh are currently sequencing the genomes of the novel coronavirus, he said. Other CSIR institutes are also expected to join the process. "We have so far submitted 53 genome sequences to the GISAID (Global Initiative on Sharing All Influenza Data). By May 15, we intend to submit additional 450 genome sequences," Mande said, adding all 53 have been sequenced by the scientists at the IGIB.
   'Feluda': Made-in-India paper-based strip for rapid, mass testing for Covid-19  2020/05/06 04:52:59 Economic Times India
NEW DELHI: A lab of the Council of Scientific and Industrial Research (CSIR) which developed ‘Feluda’ — a paper-based test strip for Covid-19 which is named after the fictional detective created by Satyajit Ray — on Tuesday joined hands with Tata Sons for its deployment and widespread use for rapid mass testing on ground as early as this month end.A completely indigenous scientific invention, 'Feluda' has been designed for mitigating the ongoing Covid-19 situation and to cater to mass testing. Its main advantages are its affordability, relative ease of use and non-dependency on expensive Q-PCR machines.The 'Feluda' is developed by the the CSIR’s Institute of Genomics and Integrative Biology (IGIB)."The CSIR labs such as CSIR-IGIB have been working on deep science and developing cutting edge technology and I am happy to see that the leading industry, TATA Group, is partnering towards its deployment. The strong partnership with industry in tackling the novel coronavirus has been the hallmark of the CSIR’s strategy in mitigation of Covid1-9," said Shekhar C Mande, director general, CSIR.
   CSIR-CCMB developing digital platform to help in surveillance of coronavirus spread  2020/04/16 20:25:00 The Financial Express
CCMB and Institute of Genomics and Integrative Biology (IGIB), New Delhi are working together on the whole genome sequencing of the SARS-CoV-2 virus isolates which will help them to understand the evolution of the virus and its spread route.
   2018 In The Numbers And What It Means For 2019 - Part II: Investment Grade Fixed Income  2019/01/11 17:09:10 Seeking Alpha
   Has Delhi's coronavirus curve plateaued?  2020/07/22 13:39:09 Economic Times India
At the core of Delhi's transition from a corona capital to a model city where the number of COVID-19 cases has been consistently falling is possibly its testing strategy, say experts as they try to decipher the trajectory of the disease. Though there are no precise answers to the many questions of whether the Delhi curve has plateaued, dipped decisively or reached its peak, a close examination of testing patterns could hold the key.While some scientists believe ramped up testing has helped in breaking the transmission chain, there are others who say the reduced numbers could be because of the focus on the rapid antigen test that can throw up false negatives. Testing helps in identifying and isolating the infected, thus breaking the transmission chain, said Anurag Agarwal, director of the Institute of Genomics and Integrative Biology (IGIB). Ever since the antigen tests came, many more have been tested than previously. It breaks the chain, then they go into isolation. The number of people that each infected person infects goes down if you find them early, Agarwal told PTI.In virologist Shahid Jameel's view, rapid antigen tests don't have the same accuracy as RT-PCR tests.
   CSIR submits 53 genome sequences of coronavirus to global body; to share 450 more by May 15  2020/05/07 07:36:20 Economic Times India
Amidst concerns that coronavirus have undergone mutation and the new strain maybe more contagious, India's premier R&D organisation, CSIR, has submitted as many as 53 genome sequences of the virus to a global genome database, a move that may help in better understanding of the virus and developing a vaccine. The Council for Scientific and Industrial Research (CSIR) is also planning to submit additional 450 genome sequence data of coronavirus by May 15, its Director General Shekhar Mande told PTI. CSIR's Institute of Genomics and Integrative Biology (IGIB), Delhi, Centre for Cellular and Molecular Biology (CCMB), Hyderabad and Institute of Microbial Technology, Chandigarh are currently sequencing the genomes of the novel coronavirus, he said. Other CSIR institutes are also expected to join the process. "We have so far submitted 53 genome sequences to the GISAID (Global Initiative on Sharing All Influenza Data). By May 15, we intend to submit additional 450 genome sequences," Mande said, adding all 53 have been sequenced by the scientists at the IGIB.
   'Feluda': Made-in-India paper-based strip for rapid, mass testing for Covid-19  2020/05/06 04:52:59 Economic Times India
NEW DELHI: A lab of the Council of Scientific and Industrial Research (CSIR) which developed ‘Feluda’ — a paper-based test strip for Covid-19 which is named after the fictional detective created by Satyajit Ray — on Tuesday joined hands with Tata Sons for its deployment and widespread use for rapid mass testing on ground as early as this month end.A completely indigenous scientific invention, 'Feluda' has been designed for mitigating the ongoing Covid-19 situation and to cater to mass testing. Its main advantages are its affordability, relative ease of use and non-dependency on expensive Q-PCR machines.The 'Feluda' is developed by the the CSIR’s Institute of Genomics and Integrative Biology (IGIB)."The CSIR labs such as CSIR-IGIB have been working on deep science and developing cutting edge technology and I am happy to see that the leading industry, TATA Group, is partnering towards its deployment. The strong partnership with industry in tackling the novel coronavirus has been the hallmark of the CSIR’s strategy in mitigation of Covid1-9," said Shekhar C Mande, director general, CSIR.
   CSIR-CCMB developing digital platform to help in surveillance of coronavirus spread  2020/04/16 20:25:00 The Financial Express
CCMB and Institute of Genomics and Integrative Biology (IGIB), New Delhi are working together on the whole genome sequencing of the SARS-CoV-2 virus isolates which will help them to understand the evolution of the virus and its spread route.
   2018 In The Numbers And What It Means For 2019 - Part II: Investment Grade Fixed Income  2019/01/11 17:09:10 Seeking Alpha
   Has Delhi's coronavirus curve plateaued?  2020/07/22 13:39:09 Economic Times India
At the core of Delhi's transition from a corona capital to a model city where the number of COVID-19 cases has been consistently falling is possibly its testing strategy, say experts as they try to decipher the trajectory of the disease. Though there are no precise answers to the many questions of whether the Delhi curve has plateaued, dipped decisively or reached its peak, a close examination of testing patterns could hold the key.While some scientists believe ramped up testing has helped in breaking the transmission chain, there are others who say the reduced numbers could be because of the focus on the rapid antigen test that can throw up false negatives. Testing helps in identifying and isolating the infected, thus breaking the transmission chain, said Anurag Agarwal, director of the Institute of Genomics and Integrative Biology (IGIB). Ever since the antigen tests came, many more have been tested than previously. It breaks the chain, then they go into isolation. The number of people that each infected person infects goes down if you find them early, Agarwal told PTI.In virologist Shahid Jameel's view, rapid antigen tests don't have the same accuracy as RT-PCR tests.
   CSIR submits 53 genome sequences of coronavirus to global body; to share 450 more by May 15  2020/05/07 07:36:20 Economic Times India
Amidst concerns that coronavirus have undergone mutation and the new strain maybe more contagious, India's premier R&D organisation, CSIR, has submitted as many as 53 genome sequences of the virus to a global genome database, a move that may help in better understanding of the virus and developing a vaccine. The Council for Scientific and Industrial Research (CSIR) is also planning to submit additional 450 genome sequence data of coronavirus by May 15, its Director General Shekhar Mande told PTI. CSIR's Institute of Genomics and Integrative Biology (IGIB), Delhi, Centre for Cellular and Molecular Biology (CCMB), Hyderabad and Institute of Microbial Technology, Chandigarh are currently sequencing the genomes of the novel coronavirus, he said. Other CSIR institutes are also expected to join the process. "We have so far submitted 53 genome sequences to the GISAID (Global Initiative on Sharing All Influenza Data). By May 15, we intend to submit additional 450 genome sequences," Mande said, adding all 53 have been sequenced by the scientists at the IGIB.
   'Feluda': Made-in-India paper-based strip for rapid, mass testing for Covid-19  2020/05/06 04:52:59 Economic Times India
NEW DELHI: A lab of the Council of Scientific and Industrial Research (CSIR) which developed ‘Feluda’ — a paper-based test strip for Covid-19 which is named after the fictional detective created by Satyajit Ray — on Tuesday joined hands with Tata Sons for its deployment and widespread use for rapid mass testing on ground as early as this month end.A completely indigenous scientific invention, 'Feluda' has been designed for mitigating the ongoing Covid-19 situation and to cater to mass testing. Its main advantages are its affordability, relative ease of use and non-dependency on expensive Q-PCR machines.The 'Feluda' is developed by the the CSIR’s Institute of Genomics and Integrative Biology (IGIB)."The CSIR labs such as CSIR-IGIB have been working on deep science and developing cutting edge technology and I am happy to see that the leading industry, TATA Group, is partnering towards its deployment. The strong partnership with industry in tackling the novel coronavirus has been the hallmark of the CSIR’s strategy in mitigation of Covid1-9," said Shekhar C Mande, director general, CSIR.
   CSIR-CCMB developing digital platform to help in surveillance of coronavirus spread  2020/04/16 20:25:00 The Financial Express
CCMB and Institute of Genomics and Integrative Biology (IGIB), New Delhi are working together on the whole genome sequencing of the SARS-CoV-2 virus isolates which will help them to understand the evolution of the virus and its spread route.
   2018 In The Numbers And What It Means For 2019 - Part II: Investment Grade Fixed Income  2019/01/11 17:09:10 Seeking Alpha

 twitter  (公式ツイッターやCEOツイッターなど)